Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Influencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

Lupin has received tentative approval from the Food and Drug Administration for darunavir, cobicistat, emtricitabine, and ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...